PRODUCT LITERATURE

Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial

---

Adapalene gel 0.3% was significantly superior to adapalene gel 0.1% and vehicle in success rate,
total lesion count, and inflammatory lesion count. A consistent, dose-dependent effect was demonstrated for all efficacy measures. Signs and symptoms were mostly mild to moderate and transient in nature.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Evalen

Specific Detail Info

J Am Acad Dermatol 2006;54:242-50

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment